Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.

about

Prognostic value of genetic mutations in adolescent and young adults with acute myeloid leukemia.Acute myelogenous leukemia in adolescents and young adults.

P2860

Q47805959-7AECB9F0-7BA1-42D4-BD27-2BCD891261D8 Q52318200-3C737BF4-22C0-4611-924C-F7510E824EEE

P2860

Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.

Item

http://www.wikidata.org/entity/Q40781300

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Outcome of adolescent patients ...... ated with pediatric protocols.

@en

type

Item

label

Outcome of adolescent patients ...... ated with pediatric protocols.

@en

prefLabel

Outcome of adolescent patients ...... ated with pediatric protocols.

@en

P1476

Outcome of adolescent patients ...... ated with pediatric protocols.

@en

P2093

Akio Tawa

http://www.w3.org/2001/XMLSchema#string

Akitoshi Kinoshita

http://www.w3.org/2001/XMLSchema#string

Atsushi Kikuta

http://www.w3.org/2001/XMLSchema#string

Atsushi Manabe

http://www.w3.org/2001/XMLSchema#string

Daisuke Tomizawa

http://www.w3.org/2001/XMLSchema#string

Hideki Nakayama

http://www.w3.org/2001/XMLSchema#string

Hiroki Hori

http://www.w3.org/2001/XMLSchema#string

Hiroshi Moritake

http://www.w3.org/2001/XMLSchema#string

Hiroyuki Takahashi

http://www.w3.org/2001/XMLSchema#string

Keizo Horibe

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II study by the Japan Adult Leukemia Study Group.

Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.

Improved prognosis for older adolescents with acute lymphoblastic leukemia.

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients: a report from the Children's Oncology Group.

Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.

The incidence and clinical significance of nucleophosmin mutations in childhood AML.

Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.

P2888

s12185-015-1825-x

P304

318-326

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-015-1825-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

102

http://www.w3.org/2001/XMLSchema#string

P50

Akira Shimada

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26126642

http://www.w3.org/2001/XMLSchema#string

P921

teenager

Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.

about

P2860

P2860

Outcome of adolescent patients with acute myeloid leukemia treated with pediatric protocols.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921